Skip to main navigation Skip to search Skip to main content

A Phase II, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of PROCHYMAL (ex vivo cultured adult human mesenchymal stem cells) intravenous infusion following acute myocardial infraction

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/10 → 12/31/12

Funding

  • Osiris Therapeutics Incorporated: $30,190.21